Caption Management »

Moonlake Immunot shares owned by Caption Management

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Caption Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $21M 350k 60.39
2023-09-30 $22M 388k 57.00

More positions owned by Caption Management

Cytokinetics Com New Call Option (CYTK)
Verizon Communications Put Option (VZ)
Metropcs Communications Call Option (TMUS)
Citigroup Com New Put Option (C)
Mondelez Intl Cl A Put Option (MDLZ)
stock Call Option
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Kenvue Call Option (KVUE)
Palo Alto Networks Put Option (PANW)
Sarepta Therapeutics Call Option (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
United States Steel Corporation Call Option (X)
Tal Education Group Sponsored Ads Call Option (TAL)
Zillow Group Cl C Cap Stk Call Option (Z)
Agnico Call Option (AEM)

View all positions for Caption Management

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Federated Investors
Darwin Global Management
Holocene Advisors
Alliancebernstein
Fred Alger Management
Westfield Capital Management Company
Balyasny Asset Management
TimesSquare Capital Management
Caption Management
5AM Venture Management

View all funds holding Moonlake Immunot